MRNA Jan 2025 200.000 put

OPR - OPR Delayed price. Currency in USD

Add to watchlist

88.45

0.00

(0.00%)

As of 01:07PM EDT. Market open.

Loading interactive chart…

Simply Wall St.
We Think Shareholders May Want To Consider A Review Of Moderna, Inc.'s (NASDAQ:MRNA) CEO Compensation Package
Key Insights Moderna to hold its Annual General Meeting on 6th of May CEO Stephane Bancel's total compensation includes...
Zacks
Moderna (MRNA) Gears Up for Q1 Earnings: Here's What to Expect
Investors' focus will likely be on updates on Moderna's (MRNA) expected RSV vaccine launch and its late-stage pipeline candidates when it reports first-quarter earnings.
Zacks
Unveiling Moderna (MRNA) Q1 Outlook: Wall Street Estimates for Key Metrics
Beyond analysts' top -and-bottom-line estimates for Moderna (MRNA), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended March 2024.